Foundation for Value Creation

Reliability Assurance
Message from the Division Director of the Quality & Safety Assurance Division
In Japan, women now account for approximately 45% of the workforce as more and more women havetaken on greater and more fulfilling roles in society. In addition, as society enters an era of 100-year
lifespans, the social environment that people find themselves in, especially women, is constantly changing.
Supporting women’s health is vital as they go through life events such as pregnancy, childbirth, andchildcare, in addition to helping them continue to live and work with greater meaning regardless of theirage. Each of our employees has a sense of personal pride, and as a company we strive to achieve our aimof ensuring proper manufacturing, reliable quality, and correct use of the Company’s pharmaceuticalproducts, so that all people, not just women, can lead vibrant and healthy lives.

Maiko Mori
Member of the Board of Directors,
Executive Corporate Officer,
Division Director of Quality & Safety
Assurance Division
ASKA Pharmaceutical

Basic Principles The Quality & Safety Assurance Division of ASKA Pharmaceuticalis responsible for ensuring compliance with the Law on Securing
Quality, Efficacy and Safety of Products Including Pharmaceuticals
and Medical Devices and other laws and ministerial ordinances, aswell as the Good Quality Practice (GQP), and the Good Vigilance
Practice (GVP) standards, ensuring the quality and safety of ourpharmaceutical products, and supporting a stable supply. We

carry out our responsibilities based on high ethical standards anda sense of mission so that medical professionals and patients canuse our pharmaceuticals with confidence and peace of mind.
Our basic policy is to ensure that our pharmaceuticals aremanufactured correctly, and to provide information on theproper use of our pharmaceuticals, and as such, contribute to
medical care.

Reliability Assurance Initiatives Japan relies on other countries for many raw materials,
including active ingredients. Now, more than ever, we need tostrengthen our relationships with overseas manufacturing
plants and partner companies so that we can continue toprovide a stable supply of pharmaceuticals with the same quality
and safety assurance levels that we have always done. ASKA
Pharmaceutical complies with all laws and regulations andpromotes the strengthening of quality systems, safety measures,and proper use of its products. At the same time, we maintainclose collaboration between the three officers within theMarketing Authorization Holder of Medical Products and relevant

divisions. The Quality & Safety Assurance Division undertakes
various initiatives to keep up with the latest developmentswith the aim of achieving continued growth. As such, it isrefining its expertise and information-gathering capabilities,
improving its communication and problem-solving skills, aswell as its ability to operate effectively in the English languagewith the aim of forming win-win relationships with overseas
manufacturing plants and building and developing organizations
and human resources trusted by all partner companies.
For details, please visit our website.
https://www.aska-pharma-hd.co.jp/english/csr/social/#anc6

Sales
Message from the Division Director of the Sales Division
The Sales Division covers all of Japan (six regional departments), employing approximately 200 medical
representatives (MRs). It provides information to physicians and pharmacists who are at the forefront of
medical care to ensure that ASKA Pharmaceutical products are used properly. In addition, the company’shead office supports the activities of MRs by providing promotional strategies for each product and MR
support information systems. Even when business activities were constrained during the COVID-19
pandemic, we made every effort to maximize product potential by utilizing a three-pronged approachthat effectively fused digital and real-world activities. We are committed to building the best sales force
that can meet medical needs by ‘One Step Beyond’ efforts from now on as well.

Yutaka Kaihori
Member of the Board of Directors,
Executive Corporate Officer
Division Director of Sales Division
ASKA PharmaceuticalPharmaceutical Information Provision Activities Obstetricians, gynecologists and co-medical staff support
women’s health, which is vital for women’s success. To deliver
necessary information in a timely manner, ASKA Pharmaceutical isdeveloping a hybrid approach that blends online and in-person
interviews between MRs, academic staff, and the head officemarketing department. We have been holding an increasing
number of seminars co-sponsored by academic societies andlectures that are also held in a hybrid way. We are also working
to create opportunities for online participation in various lectures
across the country, for which medical professionals have shown

42

ASKA HD REPORT 2023

strong appreciation. ASKA Pharmaceutical will continue working
to deliver the information that obstetricians and gynecologists
need, including information on the proper use of our products.
In doing so, we will
help bring about asociety wherewomen thrive.